The association between different lipid indices and hyperuricemia in older adults: a cross-sectional study

Yingkai Shen1, Shihao Wang2, Jinghan Qiu2

  • 1First College of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.

PubMed

Insights

This study found significant links between lipid indices and hyperuricemia (HUA) in older adults. The lipoprotein combination index (LCI) showed a nonlinear association, while others had linear links with HUA.

Area of Science:

  • Gerontology
  • Metabolic Health
  • Cardiovascular Epidemiology

Background:

  • Lipid-derived composite indices are linked to metabolic and cardiovascular diseases.
  • The association between lipid indices and hyperuricemia (HUA) in older adults is not well understood.
  • This study investigates lipid indices and HUA in elderly Chinese adults.

Purpose of the Study:

  • To examine the relationship between six blood lipid indices and HUA in older Chinese adults.
  • To assess the diagnostic accuracy of these lipid indices for HUA.
  • To stratify HUA association based on lipid profiles.

Main Methods:

  • Cross-sectional study of 3,040 older adults.
  • Calculation of six lipid indices: remnant cholesterol (RC), atherogenic index of plasma (AIP), Castelli's risk index-I (CRI-I), Castelli's risk index-II (CRI-II), lipoprotein combination index (LCI), and atherogenic index (AI).
  • Statistical analyses included multivariate logistic regression, restricted cubic spline (RCS) analysis, subgroup analyses, and receiver operating characteristic (ROC) curves.

Main Results:

  • 484 participants had HUA; all composite lipid indices showed positive associations with HUA.
  • RCS analysis revealed a nonlinear association between LCI and HUA; others were linear.
  • AIP demonstrated optimal diagnostic accuracy for HUA in the overall cohort and females; LCI was superior in males.

Conclusions:

  • Statistically significant associations exist between multiple lipid indices and HUA.
  • The LCI exhibits a nonlinear relationship with HUA.
  • Lipid indices show modest diagnostic accuracy for HUA (AUC 58.14%-66.03%).
Abstract

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
186
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
223
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
217
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
301
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.2K